Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 216481

QID 216481 (Type "216481" in App Search)
A newborn infant is born at 31 weeks' gestation to a G1P1 mother with a history of type 2 diabetes. During the initial newborn evaluation, he is found to have nasal flaring, expiratory grunting, and intercostal retractions. A chest radiograph is obtained and is shown in Figure A. He is emergently intubated but continues to have decreased oxygen saturation, so he is transferred to the neonatal intensive care unit. Which of the following is the most likely underlying cause of this patient's symptoms?
  • A

Bacterial infection

0%

0/0

Deficiency of type 1 pneumocytes

0%

0/0

Deficiency of type 2 pneumocytes

0%

0/0

Retention of lung fluid

0%

0/0

Viral infection

0%

0/0

  • A

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

This premature infant who was born to a mother with type 2 diabetes mellitus and presents with grunting, retractions, hypoxemia, and a "ground-glass" appearance on chest radiograph most likely has neonatal respiratory distress syndrome. This disease is caused by a deficiency of surfactant production from type 2 pneumocytes.

Neonatal respiratory distress syndrome (also known as hyaline membrane disease) is caused by a deficiency of surfactant production in immature fetal lungs. Surfactant is normally produced by type 2 pneumocytes; however, these cells mature relatively late during fetal development, so surfactant production is insufficient before 34 weeks of development. The reduced level of surfactant results in low lung compliance and subsequent atelectasis, intrapulmonary shunting, and acute lung injury. The pathophysiology of this disease should be differentiated from transient tachypnea of the newborn, which is caused by temporarily retained lung fluid.

Zhong et al. discuss the pathophysiology and treatment of neonatal respiratory distress syndrome. They find that administration of pulmonary surfactant leads to a significantly decreased incidence of bronchopulmonary dysplasia.

Figure/Illustration A shows a chest radiograph of a newborn with diffuse opacities of both lungs (yellow circles). This "ground-glass" appearance is classically seen in patients with neonatal respiratory distress syndrome.

Incorrect Answers:
Answer 1: Bacterial infection caused by group B streptococci can result in pneumonia during the neonatal period. These patients will present with fever, tachycardia, and decompensation of respiratory function. A radiograph will reveal focal consolidation.

Answer 2: Type 1 pneumocytes are thin epithelial cells that line the alveolar basement membrane. These cells may also be relatively immature in premature infants; however, the primary pathophysiology in this patient is caused by deficient surfactant production by type 2 pneumocytes.

Answer 4: Retention of lung fluid is responsible for transient tachypnea of the newborn (TTN), which can be distinguished from neonatal respiratory distress syndrome by chest radiograph. Findings consistent with TTN include hyperinflation, prominent perihilar vascular markings, edema of interlobar septae, and fluid in the fissures.

Answer 5: Viral infection with respiratory syncytial virus can cause severe respiratory distress in premature newborn infants. These patients may have a similar appearance on radiography, but this disease will present after birth with acute decompensation of respiratory function. Infants will typically present with coughing and wheezing progressing to difficulty breathing. Symptoms generally last 7-21 days. Bronchiolitis is a lower respiratory tract infection characterized by inflammation and obstruction of the small airways in the lungs, and RSV accounts for 70% of bronchiolitis cases.

Bullet Summary:
Neonatal respiratory distress syndrome is caused by a deficiency of surfactant production from type 2 pneumocytes in premature infants.

ILLUSTRATIONS:
REFERENCES (1)
Authors
Rating
Please Rate Question Quality

0.0

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(0)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options